Abstract:
There are disclosed compounds of the formula ##STR1## wherein R. sup. 1 and R. sup. 2 are each, independently, hydrogen, lower alkyl, aryl or halo, or R. sup. 1 and R. sup. 2 taken together represent ##STR2## where the dotted lines represent optional double bonds; R. sup. 3, R. sup. 4 and R. sup. 5 are each, independently, hydrogen, lower alkyl, aryl or halo; R. sup. 6 is 2-pyridinyl, 2-pyrazinyl, 2-quinolyl, 2-quinoxalinyl or any of the foregoing R. sup. 6 moieties substituted by lower alkyl, lower alkoxy, trifluoromethyl, cyano, nitro or halo; or R. sup. 6 is ##STR3## wherein R. sup. 7 is phenyl, 2-pyridinyl, 2-pyrimidinyl, 3-pyridazinyl or 2-pyrazinyl or any of the foregoing R. sup. 7 moieties substituted by lower alkyl, lower alkoxy, halo, cyano, trifluoromethyl or nitro; Z is --(CH. sub. 2). sub. n --, --O--, or ##STR4## X is lower alkylene, vinylene, O or NH; m is 1-5; n is 0-4; p is 1-4; q is 1-2; and the pharmaceutically acceptable salts thereof, and their use as antipsychotic/anxiolytic agents having a low liability for extrapyramidal side effects.